脂质体和基于的治疗方法在质母细胞瘤治疗中的最新进展
1Univ Angers, Inserm, CNRS, MINT, SFR ICAT, F-49000 Angers, France.
概括
治疗性可以增强通过血脑屏障传递药物,用于质母细胞瘤治疗. 在临床前研究中,功能化的脂质体显示出增加瘤向和抗瘤效果的前景.
科学领域:
- *纳米医学和药物输送
- * 瘤学和神经瘤学
- * 类治疗药物 类治疗药物
背景情况:
- *质母细胞瘤治疗受到血脑屏障 (BBB) 的阻碍,限制了药物透.
- * 治疗性具有针对BBB和深度瘤透的潜力.
- *体功能化的脂质体可以积极向过度表达特定受体的质母细胞.
研究的目的:
- * 审查质母细胞瘤 (GBM) 的内化机制,寻找和透.
- *要总结针对GBM的质功能化脂质体的临床前体外和体内研究.
- * 突出这一纳米系统在GBM治疗中的优势.
主要方法:
- * 关于-BBB相互作用和GBM向的文献综述.
- *分析涉及用GBM-homing功能化脂质体的研究.
- * 检查了体外和体外疗效数据.
主要成果:
- * 酸导向脂质体表明瘤细胞向和药物积累的增强.
- * 在临床前模型中观察到显著的抗瘤效应.
- * 这些纳米系统有望改善质母细胞瘤治疗结果.
结论:
- *体功能化脂质体代表了质母细胞瘤治疗的有希望的策略.
- *需要进一步的研究来克服临床翻译的生产和表征方面的挑战.
- * 需要考虑基于抗体的疗法的竞争.
更多相关视频
07:25Author Spotlight: Multimodal Imaging Strategies for Optimizing Drug Delivery and Early Detection in Glioblastoma Treatment
Published on: March 1, 2024
2.3K
09:02Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment
Published on: September 27, 2024
2.4K
相关概念视频
Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Stem Cell Therapy for Tissue Regeneration
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
